Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 61.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.639%)
Open: 61.50
High: 61.50
Low: 61.50
Prev. Close: 61.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Business Wins

9 Feb 2006 07:02

Torex Retail PLC09 February 2006 9 February 2006 TOREX RETAIL SECURES 40 MAJOR CONTRACTS TOTALLING £36 MILLION INCLUDING TWELVE NEW LUCAS DEPLOYMENTS in 2005 Further to our pre-close trading statement issued on Monday 16th January 2006,Torex Retail has confirmed business wins totalling £36M including twelvesignificant deployments of its Lucas EPoS solutions in the financial year endingDecember 2005. The company has secured more than £20M worth of contracts in the UK and Europeand has closed business worth in excess of $25M across Canada and the USA. UK Success In the UK, wins included eight major roll outs of Lucas into the existingcustomer base including RD Scott, Slaters, Co-op Home Stores, Bargain Crazy,Yeomans, Reiss, Clinkards and Texas Department Stores. Other successes includedthe implementation of Lucas in Japanese department store Mitsukoshi in RegentStreet which went live in December 2005 as well as deployments of Torex's LucasOSM solution into Roadchef and Alpha Retail in contracts worth in excess of£2.6M. The company has also secured a major IT service contract with Tesco Pharmaciesworth £1.3M over five years. The Lucas deployments further strengthen the company's worldwide market positionfor its Lucas solution set of which the EPoS elements are now installed in morethan 17,000 lanes across the UK, USA and Europe. The company's petroleum and convenience division has secured a three year £2Msupport contract with Somerfield Stores Forecourt Services to support thecompany's forecourt and technology equipment. As well as continued success for Lucas, Torex Retail has also continued to buildthe user base for the Power For Retail EPoS solution which it acquired when thecompany purchased Anker Systems in Summer 2005. The company has deployed PowerFor Retail into 35 Oddbins stores and 65 Viyella fashion outlets as well as thecontinued rollout into 300 Instore outlets. In Northern Ireland, the company hassecured a major contract to deploy its Power solution into off licence chainRussell's Cellars across 40 stores. Within the company's hospitality operation, progress has been similarly strongsince the acquisition of XN Checkout in Summer 2005. As well as securing a major technology refresh project with managed pub chainMitchells and Butlers worth in excess of £5M in the first phase, the company hasalso secured business with pub company Pathfinder worth in excess of £5M overfive years to replace EPoS technology across its estate. In addition Torex hascompleted its first phase rollout of electronic gaming terminals and displayswith Stanley Leisure with a deal worth to date of over £1.5M with further sitesalready scheduled for 2006. Further afield, the company has secured major wins with Casino Solei in Croatiaas well as with a major casino operator in Mexico City. The combined value ofthese contracts exceeds $1M and in the Far East, the company has secured Lucassolution wins with Adidas and the Wildlife Reserve (Asia's largest night safari)in Singapore. Continued European Expansion The company has also continued to secure substantial orders across Europeincluding a contract to deploy 1300 EPoS units across Netherlands textileretailer Zeeman in outlets in the Netherlands, Germany, Belgium, and Luxemburg. Other European successes include supermarket chain Jan Linders order for 235touch screens running Lucas OSM and 49 back-office installations. Torex Retail has also secured a major contract to deploy hand held terminalsrunning on a wireless network as completing the roll out of a new EPoS systemfor Netherlands based HEMA across 330 stores in the Netherlands, Belgium andGermany. In Scandinavia, Norway's largest food retailer, Nordisgruppen, has selectedTorex Retail to deploy the Lucas OSM solution in a deal worth in excess of€0.5M. Retail and hospitality operator on the Dutch railway system, Servex, isinvesting more than €1.2M to deploy Lucas OSM across 376 stations. German discount retailer Tedi is rolling out Lucas across 520 outlets and morethan 140 have been completed to date. Tedi is planning to develop more than1,000 new stores in Germany over the next two years. Other successes in Europe include the decision by pan-European pharmacyretailers Schlecker to select Torex Retail as its exclusive service andmaintenance partner responsible for managing retail technology across 13,700outlets in a two year contract. Major Growth in North America Torex Retail is continuing on a programme of rapid growth across North Americaand Canada with more than $25M worth of business secured in 2005 including a $7Mcontract to provide New Jersey based discount store chain Stein Mart with acomprehensive technology support programme covering EPoS upgrades and thedeployment of an enterprise data centre solution. Californian Department store chain Mervyns is investing more than $12M inhardware and software solutions across its estate of 275 outlets and inaddition, membership Club Warehouse BJ's has appointed Torex Retail to providehardware, software and support services totaling in excess of $5.5M. The companyhas also completed the roll out of its Lucas EPoS solution across 40 Montblancoutlets in the USA and Canada. Commenting on the continued success of the business, Torex Retail's ExecutiveChairman Chris Moore said, "This series of wins demonstrates our ability todrive organic growth within our acquired customer base as well as highlightinghow we are able to grow our offer to these customers. Importantly we havesecured a number of new name business wins and these two factors combinedillustrate the sustainability of our long term growth strategy. "Our order pipeline is at its strongest point ever and I believe that 2006 andbeyond will see us further consolidate our UK and European market leadingposition as continuing to strengthen our offering across North America. "The integration of the businesses we have acquired is now complete and we arecurrently sharing our product strategy and new approach to service andmaintenance with our customer base. "With many retailers currently looking to replace their EPoS solutions withinthe next twelve to eighteen months, I believe the outlook is excellent," ChrisMoore added. - ends - Enquiries: Torex Retail:Chris Moore, Executive Chairman 0870 300 6061 Citigate Dewe RogersonGinny Pulbrook / Seb Hoyle / Lucie Holloway 020 7638 9571 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Apr 20242:27 pmRNSResult of AGM
10th Apr 20247:15 amEQSHardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth
5th Apr 20243:52 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSFinal results for the year ended 31 December 2023
1st Mar 20247:00 amRNSNotice of Results
6th Feb 20247:00 amRNSFirst EU shipment & new distributor agreements
29th Jan 20243:02 pmRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading update for 2023
23rd Jan 20245:24 pmRNS2023 LTIP Grant
22nd Nov 20234:36 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSHPRA approval & distribution agreement in Spain
18th Sep 202310:40 amEQSHardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23
15th Sep 20234:30 pmRNSDirector/PDMR Shareholding
5th Sep 20237:01 amRNSNew sports medicine product launch
5th Sep 20237:00 amRNSInterim results
31st Aug 20231:45 pmRNSExercise of Options and Total Voting Rights
21st Aug 20237:00 amRNSNotice of interim results
17th Jul 20237:00 amRNSHalf-Year Trading Update
10th Jul 20237:00 amRNSDistribution agreement for OrthoPure® XT in the UK
25th May 20237:00 amRNSDistribution agreement with Australian Allografts
9th May 202312:00 pmRNSHolding(s) in Company
27th Apr 202312:35 pmRNSResult of AGM, Share Reorganisation &TVR
18th Apr 20237:00 amRNSProposed Share Reorganisation Timetable
5th Apr 20232:55 pmEQSHardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
5th Apr 20237:00 amRNSCEO and CFO Share Purchases
30th Mar 20237:00 amRNSHolding(s) in Company
21st Mar 20237:00 amRNSFinal results for the year ended 31 December 2022
6th Mar 20237:00 amRNSNotice of results and Investor presentation
31st Jan 20237:01 amRNSTrading update for 2022
31st Jan 20237:00 amRNSChange of Adviser
18th Jan 202310:06 amRNSHolding(s) in Company
18th Jan 20237:00 amRNSChinese distribution agreement for OrthoPure® XT
7th Dec 20227:00 amRNSProduct launch in dCELL® division
22nd Nov 20227:00 amRNSDistribution agreement - OrthoPure® XT in Germany
14th Nov 20226:05 pmRNSHolding(s) in Company
7th Nov 20222:35 pmRNSHolding(s) in Company
29th Sep 202210:13 amRNSDirector/PDMR Shareholding
27th Sep 20227:15 amEQSHardman & Co Research on Tissue Regenix (TRX): Operating leverage
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20223:31 pmRNSHolding(s) in Company
18th Aug 20225:36 pmRNSHolding(s) in Company
18th Aug 20222:10 pmRNSHolding(s) in Company
11th Aug 20224:30 pmEQSHardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct
11th Aug 202212:46 pmRNSHolding(s) in Company
11th Aug 202212:17 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSConfirmation of Interim Results
5th Aug 20223:19 pmRNSHolding(s) in Company
1st Aug 20223:14 pmRNSHolding(s) in Company
19th Jul 20222:30 pmEQSHardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential
19th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.